Compare PUK & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PUK | ALC |
|---|---|---|
| Founded | 1848 | 1945 |
| Country | Hong Kong | Switzerland |
| Employees | N/A | N/A |
| Industry | Life Insurance | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2B | 32.4B |
| IPO Year | 2001 | 2002 |
| Metric | PUK | ALC |
|---|---|---|
| Price | $27.88 | $74.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $89.38 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 03-26-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.68% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.99 |
| Revenue Next Year | $8.92 | $6.38 |
| P/E Ratio | ★ $23.76 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.61 | $61.84 |
| 52 Week High | $34.03 | $90.41 |
| Indicator | PUK | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 64.38 |
| Support Level | $27.41 | $72.60 |
| Resistance Level | $29.84 | $82.09 |
| Average True Range (ATR) | 0.42 | 1.39 |
| MACD | -0.23 | 0.45 |
| Stochastic Oscillator | 13.83 | 78.21 |
Originally established in 1848 as the Prudential Mutual Assurance, Investment, and Loan Association, Prudential has changed a lot since. Set up to sell life insurance and loans to the middle class, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life around 1985. During its time as owner of Jackson, Prudential focused on building a simple chassis-style product portfolio that allowed customers to choose from a variety of add-ons. The company also became renowned for its focus on building the internal capabilities required to support its strong product offerings, including compelling technology and a large well-trained wholesale salesforce.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.